Alvotech (ALVO) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Alvotech  (NASDAQ: ALVO)


Alvotech's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Alvotech's ROA in the fourth quarter of 2025?
Alvotech achieved a return on average assets (ROA) of 1.91 % in its fourth quarter of 2025, this is above ALVO's average return on assets of -25.06%.
Alvotech assets over the 12 months ending in its fourth quarter of 2025 are valued at $1,464 million

ROA has improved compared to -16.18% in the third quarter of 2025, due to net income growth.

However, within the Healthcare sector 224 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 2187.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Total Assets Change 8.84 % 21.75 % 16.97 % 21.75 % 31.2 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 28 -232 -232 -232 -232
Return On Assets (TTM) 1.91 % -16.18 % -16.96 % -17.61 % -18.55 %
ALVO's Total Ranking # 2187 # # # # 4174
Total Assets (TTM) in million 1,487 1,487 1,393 1,487 1,366
Seq. Total Assets Change 0 % 6.77 % -6.34 % 8.84 % 11.86 %
Seq. Net Income Change - - - - -

ALVO's 5 Years Annual ROA >> Back to ALVO Management Effectiveness >> Compare ALVO ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 26
Sector # 225
Overall # 2175

Return On Assets Statistics
High Average Low
1.88 %
-25.06 %
-58.07 %
(Dec 31 2025)   (Dec 31 2023)





Financial Statements
Alvotech's Assets $ 1,487 million ALVO's Balance sheet
Alvotech's Income $ 28 million Quarterly ALVO's Income Statement
ALVO's Income by Division See ALVO's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2020)
FY 2022
FY
Y / Y Total Assets Change 30.31 % 31.2 % 13.22 % - -
Total Assets in million 1,780 1,366 1,041 920 0
Y / Y Net Income Change - - - - -
Net Income in million 28 -232 -552 -514 0
Annual Return On Assets 1.57 % -16.97 % -52.98 % -55.84 % -

ALVO's 5 Years Annual ROA >> Back to ALVO Management Effectiveness >> Compare ALVO ROA to its Competitors



Comment on ALVO's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 1.57 % compared to prior year, due to annual net income growth of % to $27.92 million, while value of Alvotech's overall assets grew just by 30.31 % to $1,780.41 million, compared to $1,780.41 a year before.


More Return On Assets Ratios
ALVO's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ALVO's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ALVO's Competitors
Subscribers only: Roa for Alvotech's Suppliers
Subscribers only: Return On Assets for ALVO's Customers

You may also want to know
ALVO's Roi ALVO's Inventory Turnover Ratio ALVO's Growth Rates ALVO's Dividend Comparisons
ALVO's Profitability Ratios ALVO's Asset Turnover Ratio ALVO's Dividend Growth
ALVO's Roe ALVO's Valuation Ratios ALVO's Financial Strength Ratios ALVO's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector ROA
Medtronic Plc  5.07 %
Community Health Systems Inc   5.01 %
Xtant Medical Holdings Inc   4.98 %
Merit Medical Systems Inc  4.96 %
Veracyte Inc   4.88 %
U S Physical Therapy Inc  4.87 %
Organogenesis Holdings Inc   4.87 %
Labcorp Holdings Inc   4.85 %
Iqvia Holdings Inc   4.75 %
Biomarin Pharmaceutical Inc  4.68 %
Soleno Therapeutics Inc  4.61 %
Ardent Health Inc   4.52 %
Biogen Inc   4.50 %
Gyre Therapeutics Inc   4.40 %
Arcutis Biotherapeutics Inc   4.30 %
Fonar Corporation  4.27 %
The Pennant Group Inc   4.20 %
Beone Medicines Ltd   4.10 %
Bioventus Inc   3.92 %
Collegium Pharmaceutical Inc   3.88 %
Seres Therapeutics Inc   3.86 %
Fresenius Medical Care Ag  3.84 %
Henry Schein Inc   3.84 %
Pfizer Inc  3.76 %
Emergent Biosolutions Inc   3.74 %
Select Medical Holdings Corp  3.73 %
Vericel Corporation  3.67 %
Amneal Pharmaceuticals Inc   3.64 %
Teva Pharmaceutical Industries Limited  3.56 %
Pacs Group Inc   3.45 %

Date modified: 2026-07-07T09:07:10+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.